- Home
- NXT vs PEN Comparison
NXT vs PEN Comparison
Compare NXT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- PEN
- Stock Information
- Founded
- NXT 2013
- PEN 2004
- Country
- NXT United States
- PEN United States
- Employees
- NXT N/A
- PEN N/A
- Industry
- NXT Semiconductors
- PEN Medical/Dental Instruments
- Sector
- NXT Technology
- PEN Health Care
- Exchange
- NXT Nasdaq
- PEN Nasdaq
- Market Cap
- NXT 8.8B
- PEN 9.0B
- IPO Year
- NXT 2023
- PEN 2015
- Fundamental
- Price
- NXT $68.77
- PEN $265.05
- Analyst Decision
- NXT Buy
- PEN Strong Buy
- Analyst Count
- NXT 19
- PEN 16
- Target Price
- NXT $63.74
- PEN $300.47
- AVG Volume (30 Days)
- NXT 3.0M
- PEN 495.8K
- Earning Date
- NXT 07-29-2025
- PEN 07-29-2025
- Dividend Yield
- NXT N/A
- PEN N/A
- EPS Growth
- NXT N/A
- PEN 916.05
- EPS
- NXT 3.67
- PEN 3.74
- Revenue
- NXT $3,103,529,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- NXT $13.65
- PEN $14.60
- Revenue Next Year
- NXT $10.67
- PEN $14.24
- P/E Ratio
- NXT $18.74
- PEN $70.81
- Revenue Growth
- NXT 13.26
- PEN 12.92
- 52 Week Low
- NXT $30.93
- PEN $184.80
- 52 Week High
- NXT $70.14
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- NXT 64.78
- PEN 65.25
- Support Level
- NXT $63.87
- PEN $251.29
- Resistance Level
- NXT $70.14
- PEN $260.22
- Average True Range (ATR)
- NXT 3.04
- PEN 7.16
- MACD
- NXT 1.32
- PEN 2.00
- Stochastic Oscillator
- NXT 92.18
- PEN 89.33
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.